Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RGEN · against 150 other Healthcare companies of similar size
Ranked #37 of 151 · scores higher than 73% of peers
Bars: peers in each 10-point band of the growth score22 peers with a growth score of 80–89, including RGEN · Click a bar to see the companies
Mainly thanks to its earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | RGEN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 151 reported | 16.5% | 10.2% | 66% | 33% | |
| Earnings per share growthHigher is better · 110 reported | Not reported | 14.1% | — | — | 33% |
| 3-year revenue growthHigher is better · 146 reported | 3.3% | 10.9% | 16% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 7.3B USD | 97 | 74 | |
| 5 | 16.5B USD | 96 | 37 | |
| 37 | 14.6B USD | 80 | 59 | |
| 37 | 14.9B USD | 80 | 65 | |
| 37 | 9.0B USD | 80 | 78 | |
| 37 | 921.9B INR (≈$11.1B) | 80 | 82 | |
| 37 | 10.1B USD | 80 | 61 | |
| 42 | 13.7B USD | 79 | 45 | |
| 42 | 5.8B USD | 79 | 64 | |
| 42 | 5.2B CHF (≈$5.9B) | 79 | 69 | |
| 45 | 8.7B USD | 78 | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score